CRCT trades 37.1% above Wall Street's consensus target of $4.10.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRCT achieves its forward estimates and maintains a stable P/E multiple of 18.6x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Cricut, Inc. (CRCT) has a Wall Street consensus price target of $4.10, based on estimates from 4 covering analysts. With the stock currently trading at $6.52, this represents a potential downside of -37.1%. The company has a market capitalization of $1.37B.
Analyst price targets range from a low of $3.70 to a high of $4.50, representing a 20% spread in expectations. The median target of $4.10 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Sell, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 4 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CRCT trades at a trailing P/E of 18.6x and forward P/E of 18.6x. Analysts expect EPS to grow -15.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $3.95, with bear and bull scenarios of $2.49 and $5.21 respectively. Model confidence stands at 38/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SONOSonos, Inc. | $2.1B | $17.70 | $19.00 | +7.3% | Buy | 27.7x | 9 |
 LOGILogitech International S.A. | $15.0B | $104.32 | $107.00 | +2.6% | Hold | 18.9x | 19 |
 GPROGoPro, Inc. | $231M | $1.35 | $5.00 | +270.4% | Hold | — | 28 |
 SSYSStratasys Ltd. | $755M | $8.70 | $12.50 | +43.7% | Buy | 79.1x | 36 |
 DDD3D Systems Corporation | $617M | $3.78 | $6.00 | +58.7% | Hold | — | 36 |
 XMTRXometry, Inc. | $5.5B | $102.53 | $110.80 | +8.1% | Buy | 144.2x | 15 |
 BRZEBraze, Inc. | $2.9B | $25.42 | $37.27 | +46.6% | Buy | 39.6x | 25 |
 ETSYEtsy, Inc. | $6.9B | $72.77 | $85.94 | +18.1% | Buy | 21.9x | 45 |
 AMZNAmazon.com, Inc. | $2.7T | $251.52 | $326.83 | +29.9% | Buy | 19.7x | 94 |
 ADBEAdobe Inc. | $94.5B | $237.69 | $269.84 | +13.5% | Buy | 9.7x | 64 |
Quick answers to the most common questions about buying CRCT stock.
CRCT's consensus price target is $4.1, -37.1% below the current price of $6.52. The 4 analysts tracking CRCT see downside risk at present valuations.
CRCT has a consensus rating of "Sell" based on 4 Wall Street analysts. The rating breakdown is leaning bearish, with 4 Sell/Strong Sell ratings. The consensus 12-month price target of $4.1 implies -37.1% downside from current levels.
With a forward P/E of 18.6286x, CRCT trades at a relatively low valuation. The consensus target of $4.1 implies -37.1% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $4.5 for CRCT, while the most conservative target is $3.7. The consensus of $4.1 represents the median expectation. Our quantitative valuation model projects a bull case target of $5 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRCT is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRCT stock forecast based on 4 Wall Street analysts shows a consensus price target of $4.1, with estimates ranging from $3.7 (bear case) to $4.5 (bull case). The median consensus rating is "Sell". Our proprietary valuation model produces a base case fair value of $4, with bear/bull scenarios of $2/$5.
Our quantitative valuation model calculates CRCT's fair value at $4 (base case), with a bear case of $2 and bull case of $5. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 38/100.
CRCT trades at a forward P/E ratio of 18.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.6x. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CRCT, with 4 Sell ratings and a price target of $4.1 (-37.1% from current price). The "Sell" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRCT analyst price targets range from $3.7 to $4.5, a 20% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $4.1 consensus represents the middle ground. Our model's $2-$5 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.